|
Otsuka ICU Medical LLC announced plans for a $500 million expansion through a new facility and upgrades to its existing facility in Austin, with the goal of improving the long-term supply of IV solutions and supporting new IV products, according to a news release.
What’s happening: Otsuka ICU Medical will expand its existing 700,000-square-foot manufacturing site in Austin with a new 500,000-square-foot facility. The project is meant to help strengthen the supply chain of IV solutions and also bolster the transition to non-DEHP IV solutions containers.
Some context: The expansion is the first major milestone part of the joint venture by ICU Medical Inc. and Otsuka Pharmaceutical Factory Inc., which began in 2025. ICU Medical, which is headquartered in California, specializes in the development, manufacturing and sale of medical devices. Otsuka Pharmaceutical Factory, which is based out of Japan, is a global IV solutions manufacturing subsidiary of Otsuka Holdings Co.
|